Lunai Bioworks signs BrainStorm Therapeutics collaboration, targets Parkinson's data in H1 2027
The definitive agreement links Lunai Bioworks and BrainStorm Therapeutics on a Parkinson's disease program, with an initial data readout planned for the first half of 2027.